MedTrace Logo

Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma

NCT01365962 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-05-19

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research trial studies biomarkers in tumor tissue samples from patients with rhabdomyosarcoma.

Conditions

  • Sarcoma

Interventions

GENETIC

gene expression analysis

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

mass spectrometry

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Suman Malempati, MD · Doernbecher Children's Hospital at Oregon Health and Science University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2016-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01365962 on ClinicalTrials.gov